Feedback / Questions
AZD1656 - Conduit Pharmaceuticals
https://www.globenewswire.com/news-release/2025/05/09/3078252/0/en/Conduit-Pharmaceuticals-Receives-Further-Patent-Approval-For-Its-Lead-Asset-Targeting-Autoimmune-Diseases.html
May 9, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next